Mr. Wang joined Athyrium in 2016 and currently serves as an Analyst.
Prior to joining Athyrium, Mr. Wang was an investment banking analyst in the Healthcare group at Guggenheim Partners. While at Guggenheim, Mr. Wang worked on a number of transactions involving M&A and equity offerings across the biopharmaceuticals vertical.
Mr. Wang graduated with a B.S. in Biological Sciences and Applied Economics and Management from Cornell University in 2015.